These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9772810)

  • 21. The cost-effectiveness of cardiovascular medicine in Greece: brief notes.
    Vardas PE
    Hellenic J Cardiol; 2012; 53(4):333-4. PubMed ID: 22796825
    [No Abstract]   [Full Text] [Related]  

  • 22. Expensive medical technologies and "indication extrapolation": the case of implantable cardioverter-defibrillators.
    Simpson CS; Klein GJ; Hoffmaster B
    Am Heart J; 2000 Sep; 140(3):419-22. PubMed ID: 10966539
    [No Abstract]   [Full Text] [Related]  

  • 23. [Insulin pump treatment in Denmark].
    Hermansen K; Bendtson I; Borch-Johnsen K; Christiansen JS; Henriksen JE; Lervang HH; Nørgaard K
    Ugeskr Laeger; 2004 Oct; 166(42):3685-9. PubMed ID: 15508285
    [No Abstract]   [Full Text] [Related]  

  • 24. Get the lead out. Removing broken or infected pacemaker leads is a delicate art.
    Harv Heart Lett; 2008 Sep; 19(1):4-5. PubMed ID: 18946916
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effectiveness of cardiac resynchronization therapy: Futile or useful?
    Exner DV
    Can J Cardiol; 2005 Apr; 21(5):419-22. PubMed ID: 15861259
    [No Abstract]   [Full Text] [Related]  

  • 26. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac pacing and defibrillation in developing nations.
    Oto A
    Pacing Clin Electrophysiol; 1995 May; 18(5 Pt 1):1063-4. PubMed ID: 7659559
    [No Abstract]   [Full Text] [Related]  

  • 28. Implanted electronic devices at endoscopy: advice in a gray area.
    Petersen BT
    Gastrointest Endosc; 2007 Apr; 65(4):569-70. PubMed ID: 17383454
    [No Abstract]   [Full Text] [Related]  

  • 29. Reducing mortality in patients with advanced cardiovascular disease: subgroups, subgroups and more subgroups..
    Saksena S
    J Interv Card Electrophysiol; 2004 Feb; 10(1):7-8. PubMed ID: 15049332
    [No Abstract]   [Full Text] [Related]  

  • 30. External cardioversion in patients with implanted cardiac devices: is there a problem?
    Gammage MD
    Eur Heart J; 2007 Jul; 28(14):1668-9. PubMed ID: 17591685
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reuse of previously implanted defibrillators].
    Wolfhard U
    Versicherungsmedizin; 1996 Dec; 48(6):212-4. PubMed ID: 9082646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The zen of lead extraction: obtaining the inner piece.
    Brinker JA
    Pacing Clin Electrophysiol; 2005 Mar; 28(3):177-9. PubMed ID: 15733174
    [No Abstract]   [Full Text] [Related]  

  • 33. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implantable defibrillators. Good cost-effectiveness or supplementary expense to our hospitals?].
    Lévy S; Aliot E; Clémenty J; Kacet S; Coumel P
    Arch Mal Coeur Vaiss; 1999 Mar; 92(3):289-91. PubMed ID: 10221139
    [No Abstract]   [Full Text] [Related]  

  • 35. Implantable cardioverter/defibrillator therapy: the meaning of terms.
    Smith ER
    Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
    [No Abstract]   [Full Text] [Related]  

  • 36. Robotic implantation of resynchronization and defibrillator rhythm management systems.
    Tyers GF
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):807-9. PubMed ID: 16922994
    [No Abstract]   [Full Text] [Related]  

  • 37. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Implantable drug pumps for spinal opioid analgesia: technical solutions and problems].
    Kehnscherper H; Rudolph S; Freitag B
    Anaesthesiol Reanim; 2004; 29(3):74-8. PubMed ID: 15317359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of implantable cardioverter-defibrillators.
    Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
    Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
    [No Abstract]   [Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillators.
    Mack MJ
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.